Passage Bio, Inc. (PASG)
NASDAQ·Healthcare·Biotechnology
$5.44
-1.09%
Mkt Cap $27.94M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
Implied Upside
+83.8%
Consensus $10.00 vs current $5.44
NASDAQ·Healthcare·Biotechnology
$5.44
-1.09%
Mkt Cap $27.94M
No recent rating data.
Price Target (4 analysts)
$10.00
Range $7.00 – $15.00
+83.8%
Consensus $10.00 vs current $5.44